PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Clinical trials have been performed on Agaricus blazei Murill Kyowa for anticancer effects [PMID:35910346]. In vitro and in vivo studies show inhibition of prostate cancer cell proliferation and suppression of tumor growth [PMID:18926679].
Ethyl acetate extracts showed significant glucose-lowering activity and alpha-glucosidase inhibition in vitro, comparable to metformin [PMID:31993159].
In vivo studies in mice showed increased serum IgG levels, increased T-cell numbers in the spleen, and elevated phagocytic capability [PMID:17639159].
Polysaccharides used in films promoted collagen deposition and repair of epidermis and dermis layers in vivo [PMID:39510455].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 36387602 (2022) — Critical review on chemical compositions and health-promoting effects of mushroom Agaricus blazei Murill. · Current research in food science
- 2.PMID: 34022313 (2021) — Polysaccharides and extracts from Agaricus brasiliensis Murill - A comprehensive review. · International journal of biological macromolecules
- 3.PMID: 38731895 (2024) — Anti-Photodamage Effect of Agaricus blazei Murill Polysaccharide on UVB-Damaged HaCaT Cells. · International journal of molecular sciences
- 4.PMID: 18317543 (2008) — The Medicinal Mushroom Agaricus blazei Murrill: Review of Literature and Pharmaco-Toxicological Problems. · Evidence-based complementary and alternative medicine : eCAM
- 5.PMID: 12708495 (2003)